CCR5 Antagonist for HIV

Background
HIV (+) volunteers are needed to participate in a research study involving an investigational CCR5 Antagonist. (A new class of drugs for HIV infection.)

Participants may be paid up to $1,500 (for completion of 14 visits)

Those who qualify will receive routine medical examinations and lab tests in addition to the monetary compensation.

Inclusion Criteria
1. T-Cell count equal to or greater than 300
2. Viral load equal to or greater than 5,000
3. Do not have active Hepatitis B and/or C

For more information please contact Dr. Jacob Lalezari of Quest Clinical Research at (415) 353-0800